Trial intelligence / Profile preview

Survey of Inhibitors in Plasma-Product Exposed Toddlers

IRCT201104106161N1Phase 4Completed

Sponsor
Fondazione Angelo Bianchi Bonomi
Start
Apr 2009
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of plasma-derived factor VIII in hemophilia A, sponsored by Fondazione Angelo Bianchi Bonomi. Primary endpoint: Incidence of factor VIII inhibitors. Started Apr 2009; status: completed.

02

Drugs

plasma-derived factor VIII
03

Conditions

hemophilia A

Beyond the preview

Go deeper on IRCT201104106161N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201104106161N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call